PODD - צמיחת הכנסות ב-12 חודשים נגררים Insulet Inc.

Insulet Corporation (PODD) relies on wireless drug delivery technologies and the expansion of its customer base via manufacturing plants in the US and Mexico. The trailing four-quarter annual revenue growth rate reflects a trend where the value 26.70 indicates its development status. This is further supported by a flawless reputation as an innovator among patients and rigorous sterile control at automated facilities in China and the US.
insulet.com (PODD) - פילוחי מדדים ודוחות פיננסיים

This indicator measures the growth rate of total revenue over a rolling twelve-month period, reflecting the actual expansion speed of the company's commercial income. The price action of the trailing twelve-month (LTM) revenue growth allows for an assessment of Insulet Corporation (PODD) stability within the narrow niche of wearable pumps amid the global patient shift toward automated diabetes treatment systems, revealing the real effectiveness of its market capture.